Angelo Dipasquale

459 total citations
23 papers, 217 citations indexed

About

Angelo Dipasquale is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angelo Dipasquale has authored 23 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angelo Dipasquale's work include Glioma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (6 papers). Angelo Dipasquale is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (6 papers). Angelo Dipasquale collaborates with scholars based in Italy, United States and United Kingdom. Angelo Dipasquale's co-authors include Armando Santoro, Matteo Simonelli, Pasquale Persico, Elena Lorenzi, Federico Pessina, Pierina Navarria, Letterio S. Politi, Giuseppe Lombardi, Marta Scorsetti and Emanuela Morenghi and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Angelo Dipasquale

22 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Dipasquale Italy 9 80 66 55 46 36 23 217
Atulya Aman Khosla United States 8 70 0.9× 61 0.9× 60 1.1× 26 0.6× 74 2.1× 52 221
Faye Robertson United Kingdom 6 75 0.9× 96 1.5× 65 1.2× 29 0.6× 23 0.6× 7 259
Kaleigh Fetcko United States 6 86 1.1× 100 1.5× 47 0.9× 21 0.5× 67 1.9× 9 273
Marcus Matsushita Brazil 7 55 0.7× 85 1.3× 49 0.9× 38 0.8× 38 1.1× 12 179
Megan M. Herr United States 9 42 0.5× 96 1.5× 57 1.0× 21 0.5× 17 0.5× 35 256
Yanwen Wang China 10 20 0.3× 140 2.1× 59 1.1× 33 0.7× 68 1.9× 25 280
Sophia Balderman United States 8 49 0.6× 59 0.9× 78 1.4× 17 0.4× 11 0.3× 19 234
Daniel A. Wattson United States 5 34 0.4× 60 0.9× 46 0.8× 31 0.7× 53 1.5× 6 205
Cosette D. Champion United States 8 91 1.1× 117 1.8× 29 0.5× 48 1.0× 107 3.0× 10 264
Heike Weidner Germany 11 88 1.1× 43 0.7× 103 1.9× 19 0.4× 16 0.4× 17 278

Countries citing papers authored by Angelo Dipasquale

Since Specialization
Citations

This map shows the geographic impact of Angelo Dipasquale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Dipasquale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Dipasquale more than expected).

Fields of papers citing papers by Angelo Dipasquale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Dipasquale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Dipasquale. The network helps show where Angelo Dipasquale may publish in the future.

Co-authorship network of co-authors of Angelo Dipasquale

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Dipasquale. A scholar is included among the top collaborators of Angelo Dipasquale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Dipasquale. Angelo Dipasquale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borea, Roberto, Eleonora Nicolò, Diego de Miguel‐Pérez, et al.. (2025). Cancer in a drop: Advances in liquid biopsy in 2024. Critical Reviews in Oncology/Hematology. 213. 104776–104776. 6 indexed citations
2.
Padovan, Marta, Matteo Simonelli, Amedeo De Nicolò, et al.. (2025). A phase 1, first-in-human study of regorafenib plus temozolomide with or without radiotherapy in patients with newly diagnosed MGMT methylated, IDHwt glioblastoma: The REGOMA-2 trial.. Journal of Clinical Oncology. 43(16_suppl). 2068–2068.
3.
Reduzzi, Carolina, Eleonora Nicolò, Konstantinos Venetis, et al.. (2024). Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors. Critical Reviews in Oncology/Hematology. 203. 104483–104483. 8 indexed citations
4.
Losurdo, Agnese, Angelo Dipasquale, Laura Giordano, et al.. (2024). Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram. Frontiers in Immunology. 15. 1323151–1323151. 1 indexed citations
5.
Dipasquale, Angelo, Enrico Franceschi, Laura Giordano, et al.. (2024). Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study. ESMO Open. 9(6). 103485–103485. 3 indexed citations
6.
Losurdo, Agnese, Antonio Di Muzio, Beatrice Claudia Cianciotti, et al.. (2024). T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression. Cancers. 16(3). 603–603. 7 indexed citations
7.
Dipasquale, Angelo, Agnese Losurdo, Pasquale Persico, et al.. (2023). Brain metastases and next-generation anticancer therapies: a survival guide for clinicians. Critical Reviews in Oncology/Hematology. 194. 104239–104239. 2 indexed citations
8.
Persico, Pasquale, Elena Lorenzi, Agnese Losurdo, et al.. (2022). Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations. Cancers. 14(5). 1125–1125. 14 indexed citations
9.
Simonelli, Matteo, Pasquale Persico, Arianna Capucetti, et al.. (2021). Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes. Neuro-Oncology Advances. 3(1). vdab160–vdab160. 1 indexed citations
10.
Dipasquale, Angelo, Pasquale Persico, Elena Lorenzi, et al.. (2021). COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report. Journal for ImmunoTherapy of Cancer. 9(2). e001870–e001870. 11 indexed citations
11.
Persico, Pasquale, Elena Lorenzi, Angelo Dipasquale, et al.. (2021). Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives. Journal of Clinical Medicine. 10(7). 1367–1367. 21 indexed citations
12.
13.
Lombardi, Giuseppe, Alessandro Della Puppa, Marco Pizzi, et al.. (2021). An Overview of Intracranial Ependymomas in Adults. Cancers. 13(23). 6128–6128. 8 indexed citations
14.
Lorenzi, Elena, Matteo Simonelli, Pasquale Persico, Angelo Dipasquale, & Armando Santoro. (2021). Risks of molecular targeted therapies to fertility and safety during pregnancy: a review of current knowledge and future needs. Expert Opinion on Drug Safety. 20(5). 503–521. 13 indexed citations
15.
Dipasquale, Angelo, et al.. (2020). Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care. Frontiers in Oncology. 10. 926–926. 4 indexed citations
16.
Simonelli, Matteo, Angelo Dipasquale, Francesca Orzan, et al.. (2020). Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic?. Critical Reviews in Oncology/Hematology. 146. 102879–102879. 21 indexed citations
17.
Muglia, Riccardo, Matteo Simonelli, Federico Pessina, et al.. (2020). Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis. European Radiology. 31(6). 4079–4086. 38 indexed citations
18.
Lombardi, Giuseppe, Matteo Simonelli, Luisa Bellu, et al.. (2020). Defining the prognostic role of MGMT methylation value by pyrosequencing assay in glioblastoma patients: A large Italian multicenter study.. Journal of Clinical Oncology. 38(15_suppl). 2539–2539. 1 indexed citations
19.
Caccese, Mario, Tamara Ius, Matteo Simonelli, et al.. (2020). Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study. International Journal of Molecular Sciences. 21(18). 6716–6716. 19 indexed citations
20.
Rodriquenz, Maria Grazia, Sabrina Rossi, Riccardo Ricci, et al.. (2016). Gastrointestinal stromal tumors (GISTs) and second malignancies. Medicine. 95(38). e4718–e4718. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atulya Aman Khosla Breakdown of academic impact, for papers by Faye Robertson Breakdown of academic impact, for papers by Kaleigh Fetcko Breakdown of academic impact, for papers by Marcus Matsushita Breakdown of academic impact, for papers by Megan M. Herr Breakdown of academic impact, for papers by Yanwen Wang Breakdown of academic impact, for papers by Sophia Balderman Breakdown of academic impact, for papers by Daniel A. Wattson Breakdown of academic impact, for papers by Cosette D. Champion Breakdown of academic impact, for papers by Heike Weidner
Rankless by CCL
2026